Thomas V.
de la Bastide III

Tom de la Bastide is the Global Co-Head of Finance and a partner in the Finance Group. He specializes in financings for leveraged buyouts, alternative lending transactions for hedge funds, mezzanine funds, banks and other lenders, corporate debt issuances for Fortune 500 companies and complex debt restructurings. Tom has been consistently recognized for his work by leading publications, including  The Legal 500, and is recognized as one of Lawdragon’s 500 Leading Dealmakers.

Working with clients across a broad spectrum of financing transactions, Tom represents major corporations, financial institutions, hedge funds and private equity sponsors in their acquisition financings, secured and unsecured bank financings, mezzanine financings, second-lien financings, asset-based loans, restructurings and DIP and exit facilities.

He advises clients in domestic and international lending transactions, including acquisitions, divestitures, structured financings, restructurings and derivative products. Tom also has significant experience in junior capital lending transactions, intercreditor issues and secured creditor and bankruptcy rights. His clients represent a variety of industries, including consumer products, manufacturing, media and entertainment, apparel, food and beverage, publishing, oil and gas, automotive and technology.

Some of Tom’s private equity and funds representations include:

• Angelo Gordon in the financing of its $2.7 billion sale to TPG
• Ares Management in numerous transactions, including multiple credit agreements, credit facilities and acquisition financings for companies including Airtron Heating & Air Conditioning, Bombardier Aerospace, Commercial Trailer Leasing, Form Technologies, FTAI Infrastructure, Gamut Capital Management, Greenbrier Hotel, Hornbeck Offshore Services, Infrastructure and Energy Alternatives, Insightful Science, Integrated Power Services, Panoramic Health, Savers Thrift Chain, STP Acquisition, Virgin Voyages, Virtus Industries and Wastequip, among others
• Brigade Capital Management in the financing aspects of its partnership with investment firm Macellum Capital Management to acquire the Family Dollar business segment of Dollar Tree, Inc. for $1.007 billion
• The Carlyle Group in the financing aspects of its acquisition of Content Partners, and in Content Partners’ subsequent acquisition of a portfolio of interests in 200 films and several hundred episodes of television
• Clearlake Capital Partners in the financing aspects of its acquisition of Crash Champions, and on a $90 million capital call facility provided by Macquarie Bank Limited relating to Clearlake’s existing investment in Ivanti
• Florida Cancer Specialists & Research Institute, LLC (FCS) in the approximately $2.5 billion all-cash sale of a 70% stake in its internal business and administrative services arm, Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures), to McKesson Corporation
• Kohlberg & Co. in numerous transactions, including its $1.2 billion credit facilities in connection with its acquisition of PCI Pharma; its $925 million credit facilities in connection with its acquisition of Parts Authority; its $756 million credit facilities in connection with SpecialtyCare’s refinancing; the financing in connection with the acquisition of Worldwide Clinical Trials, DecoPac, Myers EPS and Ob Hospitalist Group, Worldwide Clinical Trials among others
• LongRange Capital, in the financing aspects of its $300 million acquisition of all the equity interests in US Synthetic Corporation from ChampionX Corporation
• OceanSound Partners in the financing aspects of its acquisition of PAR Excellence from Northlane Capital Partners
• The Chatterjee Group in numerous transactions, including alongside private equity firm Rhone Group and Illuminate Buyer in connection with $1.3 billion in credit facilities to fund a portion of the acquisition of McDermott International Inc.’s Lummus Technology Group
• Palladium Equity Partners in its acquisition of Fiven, a Norway-based specialty materials company, from OpenGate Capital
• PCI Pharma in its $4 billion refinancing
• Stellex Capital Management in the financing aspects of its acquisition of ICS Holding, a premier U.S. electrical contractor.
• Wellspring Capital Management in its acquisition of SupplyOne Inc. as well as Hoffmaster in the financing for the acquisition of an equity interest in Paterson Pacific Parchment and related subsequent refinancings
• Additional representative clients include Centerbridge Partners, GP Investments, KPS Capital Partners, Pamplona Capital

Some of Tom’s public company representations include:

• Bioverativ in the financing aspects of its $11.6 billion acquisition by Sanofi
• Continental Grain in the M&A and financing aspects of its all-cash acquisition, alongside global food corporation Cargill, of Sanderson Farms Inc. representing a total equity value of $4.53 billion
• Conair in its sale to affiliates of American Securities, including the financing aspects of the transaction
• Dana Inc. in the $1.7 billion senior secured credit facilities in connection with its acquisition of the Drive Systems segment of the Oerlikon Group, as well as in the company’s $500 million bridge facility and additional $150 million revolving credit facilities
• Elanco Animal Health in the $5 billion senior secured credit facilities in connection with the acquisition of Bayer Animal Health
• Encana Corp. in the financing aspects of its $7.7 billion acquisition of Newfield Exploration Company
• Michael Kors in numerous transactions, including the financing aspects of its $1.35 billion acquisition of Jimmy Choo and over $1 billion in credit facilities
• Nellson Nutraceutical in an “amend & extend” transaction for its senior secured credit facilities
• Revlon in its $1.83 billion term loan financing, successful out-of-court exchange offer, two exit financing facilities: (i) a $1.4 million term loan facility and (ii) a $325 million asset-based revolving facility, and multiple refinancings
• Virtu Financial in its $650 million senior secured term loan facility in connection with the refinancing of existing indebtedness
• Taylor Morrison Home Corp. in its $800 million senior secured credit facilities in connection with the refinancing of existing indebtedness

Some of Tom’s corporate reorganization, private credit and refinancing representations include:

• Charlesbank Capital Partners as arranger and lender under a $350 million first lien term loan facility with the parent company of FullBeauty. The facility will refinance and replace certain term loans incurred by FullBeauty upon its exit from its 2019 pre-arranged bankruptcy
• JPMorgan Chase & Co. as one of the term lenders to Electrical Components International in connection with a $905 million term loan, $95 million delayed draw term loan commitment and a $100 million super-priority revolver for the borrower’s refinancing of its existing 1L and 2L term loans
• Rotech Healthcare in the financing aspects of its $625 million refinancing, consisting of a senior secured revolving credit facility and senior secured term loan, a portion of the proceeds of which were used to pay a special dividend to the indirect parent of the borrower
• TPG in the planned chapter 11 proceedings of its portfolio company, J.Crew Group, Inc. and in the restructuring proceedings of its portfolio company, Cirque du Soleil Entertainment Group
• Towerbrook Capital Partners in the successful out-of-court restructuring of its portfolio company J.Jill